• Recurrent Pericarditis Slashed in Drug Trial; Echo in Prone COVID-19; Lipid Gene Editing

    11 days ago - By MedPageToday

    Weekly injections of rilonacept, a novel interleukin-1 alpha and beta blocker, reduced recurrent pericarditis by 96% compared with placebo in topline results from the pivotal phase III RHAPSODY trial, Kiniksa Pharmaceuticals...
    Read more ...